Results 321 to 330 of about 9,902,006 (336)
Some of the next articles are maybe not open access.
Thyroid, 2021
Background: The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) comprises four entities, including the postvaccination phenomenon, which appears after being exposed to adjuvants in vaccines that increase the immune response. There is limited
O. Vera-Lastra +5 more
semanticscholar +1 more source
Background: The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) comprises four entities, including the postvaccination phenomenon, which appears after being exposed to adjuvants in vaccines that increase the immune response. There is limited
O. Vera-Lastra +5 more
semanticscholar +1 more source
Graves' disease in clinical perspective.
Frontiers in Bioscience, 2019Graves' disease (GD) is the most common cause for hyperthyroidism in iodine-replete areas. The disease is caused by the appearance of stimulating TSH receptor autoantibodies (TRAb) leading to hyperthyroidism. Blocking and neutral TRAb have, however, also
M. Ehlers, M. Schott, S. Allelein
semanticscholar +1 more source
Graves' disease: Epidemiology, genetic and environmental risk factors and viruses.
Best practice & research. Clinical endocrinology & metabolism, 2020A. Antonelli +12 more
semanticscholar +1 more source
Best practice & research. Clinical endocrinology & metabolism, 2020
A. Antonelli +12 more
semanticscholar +1 more source
A. Antonelli +12 more
semanticscholar +1 more source
Graves disease: latest understanding of pathogenesis and treatment options
Nature Reviews EndocrinologyG. Lanzolla, Michele Marinò, F. Menconi
semanticscholar +1 more source
Can we predict relapse in Graves' disease? Results from a systematic review and meta-analysis.
European Journal of Endocrinology, 2017T. Struja +6 more
semanticscholar +1 more source
Graves' disease: Introduction, epidemiology, endogenous and environmental pathogenic factors.
Annales d'Endocrinologie, 2018J. Wemeau +4 more
semanticscholar +1 more source